{"id":"NCT03029208","sponsor":"GlaxoSmithKline","briefTitle":"Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)","officialTitle":"A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-05-11","primaryCompletion":"2020-09-24","completion":"2020-09-24","firstPosted":"2017-01-24","resultsPosted":"2021-10-20","lastUpdate":"2021-10-20"},"enrollment":312,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anaemia"],"interventions":[{"type":"DRUG","name":"Daprodustat","otherNames":[]},{"type":"DRUG","name":"Darbepoetin alfa","otherNames":[]},{"type":"DRUG","name":"Iron therapy","otherNames":[]}],"arms":[{"label":"Daprodustat treated anemic subjects","type":"EXPERIMENTAL"},{"label":"Darbepoetin alfa treated anemic subjects","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this multi-center study is to evaluate the efficacy and safety of daprodustat in subjects with anemia associated with CKD.","primaryOutcome":{"measure":"Mean Change From Baseline in Hemoglobin (Hgb) During Evaluation Period (Week 28 to Week 52)","timeFrame":"Baseline (Pre-dose on Day 1) and evaluation period (Week 28 to Week 52)","effectByArm":[{"arm":"Daprodustat","deltaMin":1.02,"sd":0.086},{"arm":"Darbepoetin Alfa","deltaMin":1.12,"sd":0.085}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":22},"locations":{"siteCount":111,"countries":["United States","Argentina","Australia","Canada","Germany","India","Italy","Malaysia","Mexico","Poland","Russia","South Africa","South Korea","Spain","United Kingdom"]},"refs":{"pmids":["36005278","35377393"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":52,"n":157},"commonTop":["Hypertension","Dialysis hypotension","Diarrhoea","Headache","Upper respiratory tract infection"]}}